89Zr-DFO-D2101

N/A

Report date: 2025/10/28 16:07:02

Base Information

Drug Name89Zr-DFO-D2101

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionCadherin-17 binders

TargetsCadherin-17

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHunter College Of City University Of New York

China Registration ClassN/A

Develop Information

Active CompaniesHunter College Of City University Of New York

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A